Vir Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-07 09:36:46 ET VIR

Published on 05/07/2026 at 09:36 am EDT

Vir Biotechnology, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported negative revenue was USD 0.029 million compared to revenue of USD 3.03 million a year ago. Net loss was USD 125.7 million compared to USD 120.97 million a year ago.

Basic loss per share from continuing operations was USD 0.85 compared to USD 0.88 a year ago. Diluted loss per share from continuing operations was USD 0.85 compared to USD 0.88 a year ago.